1 / 39

Management of Breast cancer in young Women D.Amer Al shikh yosef

Management of Breast cancer in young Women D.Amer Al shikh yosef Director of Kiwan cancer care centre General secretary of S.I.A.C. Breast cancer in young women Challenges and hopes. Dr Amer chikh youssef.

debbiek
Download Presentation

Management of Breast cancer in young Women D.Amer Al shikh yosef

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Management of Breast cancer in young Women D.Amer Al shikhyosef Director of Kiwan cancer care centre General secretary of S.I.A.C Breast cancer in young women Challenges and hopes Dr Amer chikhyoussef

  2. (In Asia new cases are rising substantially by around 60% in some parts over the space of 10 years the rise is particularly in younger women between 30and 40) Dr.Louis Chow medical director of comprehensive centre of breast disease Hong Kong 1st Asian breast cancer conference Delhi India 2008

  3. breast cancer incidence per 100,000 in Iran2005-2006 Montazari et al. IHSR

  4. Should treatment options for young women be more aggressive?

  5. Age that may considered as risk factor ? Risk of long term sequel of aggressive treatment ( CHF - leukemia)

  6. Although there is no biologic explanationFor the increase of risk for recurrancr one should carefully considre more rather less treatment and we also need to discus emerging stratigy .

  7. Endocrine therapy What is the role of suppression of ovarian function? Optimal duration of endocrine therapy in young women?

  8. Association of amenorrhea with survival

  9. Conclusion : • Ovarian suppression in some selected high risk patients. • Careful assessment of QL.

  10. Optimal duration of hormonal therapy for young patients? ATLAS study: 10 vs.5 years of tamoxifen

  11. Conclusion : • The standard duration 5y • in high risk N+ AIs after 5 y tamoxifen should be considered (permanent amenorrhea du to chemotherapy)

  12. Radical mastectomy or breast conserving surgery ?

  13. Fertility preservation ?

  14. Incidence of chemotherapy induced amenorrhea by regimen

  15. Thank You

More Related